Identity
- Trade Name
- ARK™ Levetiracetam Calibrator FDA UDI
- Generic Name
- Levetiracetam therapeutic drug monitoring IVD, calibrator FDA UDI
- Device Name
- The ARK™ Levetiracetam Calibrator is intended for use in calibration of the ARK™ Levetiracetam Assay. FDA UDI
- Model / Reference
- 5024-0002-00 FDA UDI
- Description
- The ARK™ Levetiracetam Calibrator is intended for use in calibration of the ARK™ Levetiracetam Assay. FDA UDI
Identifiers
- Catalog Number
- 5024-0002-00 FDA UDI
- Primary DI / UDI-DI
- 00858724003094 FDA UDI
- 510(k) Number
- K091653 FDA UDI
- FDA Product Code
- DLJ FDA UDI
- GMDN Term
- Levetiracetam therapeutic drug monitoring IVD, calibrator FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 862.3200 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Levetiracetam therapeutic drug monitoring IVD, calibrator
ARK™ Levetiracetam Calibrator by Ark Diagnostics Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Levetiracetam therapeutic drug monitoring IVD, calibrator.
Cleared under the same submission
K091653 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Ark Diagnostics Inc
Sources (1)
- FDA UDI a8cf738c-7d2d-4b82-99cc-0ba6bddcd5cc 37 fields · synced May 30, 2026